Related references
Note: Only part of the references are listed.CD4+ Type II NKT Cells Mediate ICOS and Programmed Death-1-Dependent Regulation of Type 1 Diabetes
Nadir Kadri et al.
JOURNAL OF IMMUNOLOGY (2012)
Stimulation of a shorter duration in the state of anergy by an invariant natural killer T cell agonist enhances its efficiency of protection from type 1 diabetes
R. Tohn et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Structure-guided design of an invariant natural killer T cell agonist for optimum protection from type 1 diabetes in non-obese diabetic mice
H. J. Blumenfeld et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Sulfatide-Mediated Activation of Type II Natural Killer T Cells Prevents Hepatic Ischemic Reperfusion Injury In Mice
Philomena Arrenberg et al.
GASTROENTEROLOGY (2011)
An alpha-galactosylceramide C20:2 N-acyl variant enhances anti-inflammatory and regulatory T cell-independent responses that prevent type 1 diabetes
D. Ly et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a β-linked self-glycolipid
Philomena Arrenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Immune cell crosstalk in type 1 diabetes
Agnes Lehuen et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells
Maria Blomqvist et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Carbohydrate specificity of the recognition of diverse glycolipids by natural killer T cells
Dirk M. Zajonc et al.
IMMUNOLOGICAL REVIEWS (2009)
Cross-Regulation Between Distinct Natural Killer T Cell Subsets Influences Immune Response to Self and Foreign Antigens
Philomena Arrenberg et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Human invariant Vα24+ natural killer T cells acquire regulatory functions by interacting with IL-10-treated dendritic cells
Ayako Yamaura et al.
BLOOD (2008)
Ligand-dependent induction of noninflammatory dendritic cells by anergic invariant NKT cells minimizes autoimmune inflammation
Jianxiong Wang et al.
JOURNAL OF IMMUNOLOGY (2008)
Sulfatide, A Major Lipid Component of Myelin Sheath, Activates Inflammatory Responses as an Endogenous Stimulator in Brain-Resident Immune Cells
Sae-Bom Jeon et al.
JOURNAL OF IMMUNOLOGY (2008)
Cross-regulation between type I and type IINKT cells in regulating tumor immunity: A new immunoregulatory axis
Elena Ambrosino et al.
JOURNAL OF IMMUNOLOGY (2007)
Type IINKT cell-mediated anergy induction in type INKT cells prevents inflammatory liver disease
Ramesh C. Halder et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The length of lipids bound to human CD1d molecules modulates the affinity threshold of NKT cell activation
Corinna McCarthy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
C16:0 sulfatide inhibits insulin secretion in rat β-cells by reducing the sensitivity of KATP channels to ATP inhibition
Karsten Buschard et al.
DIABETES (2006)
Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells
Dalam Ly et al.
JOURNAL OF IMMUNOLOGY (2006)
Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity
DM Zajonc et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Involvement of sulfatide in beta cells and type 1 and type 2 diabetes
K Buschard et al.
DIABETOLOGIA (2005)
Induction of regulatory properties in dendritic cells by Vα14 NKT cells
S Kojo et al.
JOURNAL OF IMMUNOLOGY (2005)
Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of α-galactosylceram ides
KOA Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
In vivo administration of the C16:o fatty acid isoform of sulfatide increases pancreatic sulfatide and enhances glucose-stimulated insulin secretion in Zucker fatty (fa/fa) rats
M Blomqvist et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2005)
CD1 assembly and the formation of CD1-antigen complexes
DL Hava et al.
CURRENT OPINION IN IMMUNOLOGY (2005)
Role of regulatory invariant CD1d-Restricted natural killer T-cells in protection against type 1 diabetes
S Hussain et al.
IMMUNOLOGIC RESEARCH (2005)
Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide
A Jahng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Beta-galactosylceramide increases and sulfatide decreases cytokine and chemokine production in whole blood cells
A Roeske-Nielsen et al.
IMMUNOLOGY LETTERS (2004)
Prevention of diabetes in nonobese diabetic mice mediated by CD1d-restricted nonclassical NKT cells
N Duarte et al.
JOURNAL OF IMMUNOLOGY (2004)
The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation
SI Fujii et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Effects of lipid chain lengths in α-galactosylceramides on cytokine release by natural killer T cells
RD Goff et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
Interleukin-4 but not interleukin-10 protects against spontaneous and recurrent type 1 diabetes by activated CD1d-restricted invariant natural killer T-cells
QS Mi et al.
DIABETES (2004)
Structural features of the acyl chain determine self-phospholipid antigen recognition by a CD1d-restricted invariant NKT (iNKT) cell
J Rauch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion
MT Wilson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Selective lack of the C16:0 fatty acid isoform of sulfatide in pancreas of type II diabetic animal models
M Blomqvist et al.
APMIS (2003)
Mouse Vα14i natural killer T cells are resistant to cytokine polarization in vivo
JL Matsuda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Developmental expression of the type I diabetes related antigen sulfatide and sulfated lactosylceramide in mammalian pancreas
M Blomqvist et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Janus-like role of regulatory inkt cells in autoimmune disease and tumour immunity
SB Wilson et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets
YN Naumov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells
K Miyamoto et al.
NATURE (2001)
Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes
S Sharif et al.
NATURE MEDICINE (2001)
The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice
S Hong et al.
NATURE MEDICINE (2001)
CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes
B Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Sulfatide promotes the folding of proinsulin, preserves insulin crystals, and mediates its monomerization
T Osterbye et al.
GLYCOBIOLOGY (2001)
Treatment with sulfatide or its precursor, galactosylceramide, prevents diabetes in NOD mice
K Buschard et al.
AUTOIMMUNITY (2001)
The glycosphingolipid sulfatide in the islets of Langerhans in rat pancreas is processed through recycling: possible involvement in insulin trafficking
P Fredman et al.
GLYCOBIOLOGY (2000)
Share Paper
